A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/29 (2006.01) A61K 47/00 (2006.01) A61K 47/30 (2006.01) A61K 47/48 (2006.01) A61P 5/18 (2006.01) A61P 19/10 (2006.01)
Patent
CA 2567056
Pharmaceutical compositions and methods are described comprising at least a parathyroid hormone peptide (PTH) preferably PTH1-34 and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of PTH, for treating or preventing osteoporosis or osteopenia in a mammalian subject, preferably a human.
L'invention concerne des compositions pharmaceutiques et des méthodes comprenant au moins un peptide associé à l'hormone parathyroïde (PTH), de préférence PTH1-34, et un ou plusieurs agents destinés à améliorer l'administration par les muqueuses du PTH, afin de traiter ou de prévenir l'ostéoporose ou l'ostéopénie chez un mammifère, de préférence un humain.
Costantino Henry R.
Kleppe Mary S.
Li Ching-Yuan
Quay Steven C.
Borden Ladner Gervais Llp
Mdrna Inc.
Nastech Pharmaceutical Company Inc.
LandOfFree
Compositions and methods for enhanced mucosal delivery of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for enhanced mucosal delivery of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for enhanced mucosal delivery of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1580932